6 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp06639 | C-Mel | CGIGAVLKVLTTGLPALISWIKRKRQQ | Synthetic analogue | Plasma memberane pore formation | MTT assay | HeLa | Cervical Cancer | IC50 = 64.15 µg/mL |
| dbacp06640 | C-Mel | CGIGAVLKVLTTGLPALISWIKRKRQQ | Synthetic analogue | Plasma memberane pore formation | MTT assay | C-33A | Cervical Cancer | IC50 = 44.76 µg/mL |
| dbacp06641 | C-Mel | CGIGAVLKVLTTGLPALISWIKRKRQQ | Synthetic analogue | Plasma memberane pore formation | MTT assay | MCF-7 | Breast Cancer | IC50 = 110.59 µg/mL |
| dbacp06642 | CM–FA | CGIGAVLKVLTTGLPALISWIKRKRQQ | Synthetic analogue | Plasma memberane pore formation | MTT assay | HeLa | Cervical Cancer | IC50 = 67.34 µg/mL |
| dbacp06643 | CM–FA | CGIGAVLKVLTTGLPALISWIKRKRQQ | Synthetic analogue | Plasma memberane pore formation | MTT assay | C-33A | Cervical Cancer | IC50 = 35.75 µg/mL |
| dbacp06644 | CM–FA | CGIGAVLKVLTTGLPALISWIKRKRQQ | Synthetic analogue | Plasma memberane pore formation | MTT assay | MCF-7 | Breast Cancer | IC50 = 10.38 µg/mL |